300255 常山藥業
按盤價 
58.090 +6.960 (+13.612%)
58.090 +6.960 (+13.612%) | 2025/06 - 中期 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -1.880 | -14.789 | -50.936 | 0.572 | 7.896 |
| 總資產報酬率 ROA (%) | -0.642 | -5.471 | -23.329 | 0.312 | 4.785 |
| 投入資產回報率 ROIC (%) | -0.705 | -5.997 | -25.330 | 0.334 | 5.154 | 邊際利潤分析 |
| 銷售毛利率 (%) | 14.538 | 16.103 | 22.502 | 44.421 | 58.181 |
| 營業利潤率 (%) | -6.826 | -24.645 | -86.946 | 0.875 | 8.827 |
| 息稅前利潤/營業總收入 (%) | 1.753 | -15.118 | -80.737 | 4.810 | 11.218 |
| 淨利潤/營業總收入 (%) | -7.368 | -25.614 | -88.494 | 0.435 | 7.792 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 167.121 | 84.075 | 48.289 | 164.295 | 96.535 |
| 價值變動淨收益/利潤總額(%) | 0.000 | -12.939 | -0.001 | 0.000 | 0.000 |
| 營業外收支淨額/利潤總額(%) | -1.246 | 1.181 | 0.436 | -12.896 | -0.610 | 償債能力分析 |
| 流動比率 (X) | 0.791 | 0.909 | 1.185 | 2.180 | 1.966 |
| 速動比率 (X) | 0.289 | 0.280 | 0.329 | 0.820 | 0.648 |
| 資產負債率 (%) | 66.972 | 66.044 | 60.846 | 49.402 | 40.805 |
| 帶息債務/全部投入資本 (%) | 60.202 | 59.456 | 54.904 | 44.558 | 35.746 |
| 股東權益/帶息債務 (%) | 62.159 | 63.150 | 79.332 | 121.839 | 176.804 |
| 股東權益/負債合計 (%) | 50.422 | 52.302 | 64.777 | 102.558 | 144.909 |
| 利息保障倍數 (X) | 0.206 | -1.539 | -12.252 | 1.192 | 4.590 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 107.221 | 80.283 | 77.324 | 53.402 | 41.278 |
| 存貨周轉天數 (天) | 566.636 | 630.661 | 671.176 | 653.827 | 605.008 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 27/10/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
